Crystal-Associated Colitis with Ulceration Leading to Hematochezia and Abdominal Pain

Meeta Desai1, Aaron Reiprich2, Nancy Khov3

  • 1Department of Internal Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pa., USA.

Insights

Medication-associated mucosal injury from ion-exchange resins like sevelamer can cause lower GI bleeding. Discontinuing these drugs resolved a patient's rectal bleeding and abdominal pain, highlighting an underrecognized cause of hematochezia.

Area of Science:

  • Gastroenterology
  • Nephrology
  • Oncology

Background:

  • Lower gastrointestinal (GI) bleeding is a frequent reason for adult hospitalization.
  • Medication-associated mucosal injury is a significant clinical issue linked to morbidity and mortality.

Observation:

  • A 45-year-old woman presented with a 3-month history of abdominal cramping and rectal bleeding.
  • Her medical history included end-stage renal disease and prior radiation therapy for endometrial carcinoma.
  • Initial evaluations suggested ischemic or radiation colitis, but histology revealed acute inflammation and ulceration with crystal fragments.

Findings:

  • Histological findings were consistent with acute inflammation and ulceration attributed to crystal fragments.
  • Sevelamer and cholestyramine, common ion-exchange resins, were identified as potential causes of mucosal damage.
  • Discontinuation of these medications led to the resolution of the patient's symptoms.

Implications:

  • This case underscores the importance of considering medication-induced mucosal injury in patients with lower GI bleeding.
  • Ion-exchange resins should be evaluated as a potential etiology for unexplained hematochezia.
  • Recognizing this underappreciated cause can prevent misdiagnosis and improve patient outcomes.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
883
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
594
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.6K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K